血清视黄醇结合蛋白4与胱抑素C和心肌梗死患者心功能及心室重构的关系
本研究为病例对照研究,纳入185例首发急性心肌梗死(AMI)患者与150例健康对照,检测入院次日血清RBP4、CysC水平,并用彩色多普勒超声评估心功能与心室重构指标。结果显示AMI组RBP4、CysC及LVEDD、LVESV、PWS、LVM均显著高于对照组,LVEF、LVRI显著低于对照组,且随Killip分级升高而恶化。Pearson分析示RBP4、CysC与LVEF、LVRI负相关,与LVEDD、LVESV、PWS、LVM正相关。ROC曲线示两者联合预测心功能损害与心室重构的AUC为0.924(0.863-0.984)和0.913(0.849-0.976),敏感度89.91%和90.14%,特异度88.92%和88.68%。
要点
- AMI患者入院次日血清RBP4(55.37±8.31 mg/L vs 43.12±6.47 mg/L)与CysC(1.58±0.49 mg/L vs 0.72±0.11 mg/L)均显著高于健康对照(P<0.05)。
- 随Killip分级I→IV升高,血清RBP4、CysC及LVEDD、LVESV、PWS、LVM逐渐升高,LVEF与LVRI逐渐降低(均P<0.05)。
- RBP4与CysC均与LVEF(r=-0.453、-0.424)和LVRI(r=-0.479、-0.443)负相关,与LVEDD、LVESV、PWS、LVM正相关(均P<0.05)。
- RBP4与CysC单独检测对AMI心功能损害和心室重构有中等预测价值,联合检测预测效能更高(AUC 0.924和0.913)。
- 该研究为单中心病例对照研究,RBP4/CysC联合检测的预测阈值与临床应用仍需前瞻性验证。
适用人群与场景
- 纳入2022年12月至2025年1月在Harrison International Peace Hospital就诊的185例首次诊断急性心肌梗死(AMI)患者为研究组,同期150例健康体检者为对照。
- AMI患者于入院第二天采集空腹外周静脉血,健康对照于体检当日晨采集。
- 原文未提及排除人群或急诊/ICU/院前具体场景。
诊断标准与关键阈值
- 心功能损害采用Killip分级评估:185例AMI患者中Killip I级64例、II级58例、III级44例、IV级19例。
- 心室重构指标包括LVESV、PWS、LVRI、LVM,心功能指标包括LVEF、LVEDD,均由彩色多普勒超声检测。
- 原文未提及RBP4或CysC的启动/停止阈值或诊断界值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为病例对照研究,样本量185例AMI患者与150例健康对照,单中心。
- AMI组RBP4(mg/L)55.37±8.31 vs 43.12±6.47,CysC(mg/L)1.58±0.49 vs 0.72±0.11,LVEDD(mm)48.02±7.17 vs 37.19±5.58,LVESV(mL)67.42±10.11 vs 48.61±7.29,PWS(mm)13.52±1.03 vs 9.36±1.10,LVM(g)244.96±36.74 vs 167.35±25.10,均P<0.05。
- AMI组LVEF 0.421±0.063 vs 0.654±0.098,LVRI(g/mL)0.85±0.13 vs 1.24±0.19,均P<0.05。
- Pearson相关:RBP4与LVEF r=-0.453、与LVRI r=-0.479、与LVEDD r=0.202、与LVESV r=0.248、与PWS r=0.285、与LVM r=0.291;CysC与LVEF r=-0.424、与LVRI r=-0.443、与LVEDD r=0.297、与LVESV r=0.267、与PWS r=0.272、与LVM r=0.228(均P<0.05)。
- ROC曲线:RBP4与CysC联合检测预测心功能损害与心室重构的AUC分别为0.924(95%CI 0.863-0.984)和0.913(95%CI 0.849-0.976),敏感度89.91%和90.14%,特异度88.92%和88.68%。
证据类型、等级与局限
- 证据类型为单中心病例对照研究。
- 局限:单中心、病例对照设计、样本量有限,RBP4/CysC联合检测的预测阈值与临床效用需前瞻性验证。
对床旁实践的改变
- 在首发AMI患者入院次日可检测血清RBP4与CysC,两者升高提示心功能损害与心室重构程度更重(与Killip分级、LVEF、LVEDD等相关)。
- RBP4与CysC联合检测对AMI心功能损害和心室重构具有较高预测价值(AUC 0.924和0.913),但原文未给出临床决策阈值,不能直接作为启动治疗的依据。
- 适用人群为首次诊断AMI的患者;不适用于非AMI人群或健康体检者作为诊断依据。
- 常见陷阱:该研究为病例对照研究,相关性不等于因果,联合检测的敏感度/特异度需在独立队列中验证。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the relationship between serum retinol-binding protein 4 (RBP4) and cystatin C (CysC) levels and cardiac function as well as ventricular remodeling in patients with myocardial infarction.
METHODS: A case control study was conducted. A total of 185 patients with first diagnosed acute myocardial infarction (AMI) who were treated at Harrison International Peace Hospital between December 2022 and January 2025 were enrolled as the research subjects, and 150 healthy subjects who underwent physical examination at the same hospital during the same period were enrolled as the controls. Fasting peripheral venous blood samples were collected on the second day after admission for AMI patients and on the morning of physical examination for healthy controls. Serum levels of RBP4 and CysC were measured by an automatic biochemical analyzer. Cardiac function indexes [left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD)] and ventricular remodeling indexes [left ventricular end-systolic volume (LVESV), left ventricular end-systolic posterior wall thickness (PWS), left ventricular remodeling index (LVRI), left ventricular mass (LVM)] were detected by color Doppler ultrasound. Pearson correlation analysis was used to analyze the correlations of serum RBP4 and CysC levels with cardiac impairment and ventricular remodeling in AMI patients. Receiver operator characteristic curve (ROC curve) was plotted to evaluate the predictive value of serum RBP4, CysC alone and their combination for cardiac impairment and ventricular remodeling in AMI patients.
RESULTS: No significant differences in gender and age were observed between the two groups (both P>0.05). Serum levels of RBP4 and CysC, as well as LVEDD, LVESV, PWS and LVM were significantly higher in the AMI group than those in the healthy control group [RBP4 (mg/L): 55.37±8.31 vs. 43.12±6.47, CysC (mg/L): 1.58±0.49 vs. 0.72±0.11, LVEDD (mm): 48.02±7.17 vs. 37.19±5.58, LVESV (mL): 67.42±10.11 vs. 48.61±7.29, PWS (mm): 13.52±1.03 vs. 9.36±1.10, LVM (g): 244.96±36.74 vs. 167.35±25.10, all P<0.05]. In contrast, LVEF and LVRI were significantly lower in the AMI group than those in the healthy control group [LVEF: 0.421±0.063 vs. 0.654±0.098, LVRI (g/mL): 0.85±0.13 vs. 1.24±0.19, both P<0.05]. Among 185 AMI patients, 64 were classified as Killip class I, 58 as class II, 44 as class III, and 19 as class IV. With the increase of Killip classification, serum RBP4 and CysC levels, LVEDD, LVESV, PWS and LVM were gradually elevated, while LVEF and LVRI were gradually decreased (all P<0.05). Pearson correlation analysis showed that serum RBP4 and CysC were negatively correlated with LVEF (r values were -0.453 and -0.424, respectively) and LVRI (r values were -0.479 and -0.443, respectively, all P<0.05), and positively correlated with LVEDD (r values werre 0.202 and 0.297, respectively), LVESV (r values were 0.248 and 0.267, respectively), PWS (r values were 0.285 and 0.272, respectively) and LVM (r values were 0.291 and 0.228, respectively, all P<0.05). ROC curve analysis indicated that serum RBP4 and CysC alone had moderate predictive value for cardiac impairment and ventricular remodeling in AMI patients, and the combined detection achieved higher predictive efficacy. The area under the ROC curve (AUC) with 95% confidence interval (95%CI) was 0.924 (0.863-0.984) and 0.913 (0.849-0.976), with sensitivity of 89.91% and 90.14%, and specificity of 88.92% and 88.68%, respectively.
CONCLUSIONS: Serum RBP4 and CysC levels are significantly elevated in AMI patients and are closely related to the severity of cardiac impairment (Killip classification, LVEF, LVEDD) and ventricular remodeling (LVESV, PWS, LVM, LVRI). Combined detection of serum RBP4 and CysC shows high predictive value for cardiac impairment and ventricular remodeling in AMI patients.
参考来源
- Niu Y, Fu J, Zhang H, et al. [Relationship between serum retinol-binding protein 4 and cystatin C and cardiac function and ventricular remodeling in patients with myocardial infarction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42563680. doi:10.3760/cma.j.cn121430-20260311-00114
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。